The single dose vaccine for the prevention of disease caused by the chikungunya virus (CHIKV) has the potential to mitigate a major public health threat, and...
This article was originally published by Contagion Live®. This version has been lightly edited. In the general population, hybrid immunity, from both natural infection with COVID-19...
Individuals with comorbidities, particularly type 2 diabetes (T2D), were considered the most vulnerable subgroups during the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory...
In a recent article published in the journal Nature Reviews Neurology, researchers discuss the efficacy of tau-targeting Alzheimer’s disease (AD) therapies and strategies that can be implemented to...
Newborns and early infants whose mothers received a maternal mRNA COVID-19 vaccine during pregnancy may be protected from different adverse outcomes, according to new data published...
A recent study published in the journal Science discussed variant-adapted boosters for coronavirus disease 2019 (COVID-19). Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have...
Recent Comments